LUMA Vision Expands Clinical Use of VERAFEYE™ in Guiding AF Ablations and Completes Key 510k Submission.
Veröffentlicht: 20.03.2026 um 09:32 Uhr, prnewswire.co.uk
View original content:https://www.prnewswire.co.uk/news-releases/luma-vision-expands-clinical-use-of-verafeye-in-guiding-af-ablations-and-completes-key-510k-submission-302718445.html
en | boerse | 68933586 |
